Adamas Pharmaceuticals, Inc. (ADMS) financial statements (2020 and earlier)

Company profile

Business Address 1900 POWELL ST., SUITE 1000
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:133211176136120122
Cash and cash equivalents665791243361
Short-term investments6715482907461
Other undisclosed cash, cash equivalents, and short-term investments(0) 32213 
Receivables761161
Inventory, net of allowances, customer advances and progress billings552   
Inventory552   
Prepaid expense333110
Other current assets010100
Other undisclosed current assets32(3)(22)(13)0
Total current assets:150228179117113124
Noncurrent Assets
Operating lease, right-of-use asset8
Property, plant and equipment243321
Long-term investments and receivables  3221336
Long-term investments  3221336
Other noncurrent assets  1000
Other undisclosed noncurrent assets13    
Total noncurrent assets:1267251638
TOTAL ASSETS:162235186142129161
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities23241691219
Accounts payable774434
Accrued liabilities161712689
Employee-related liabilities     2
Taxes payable     5
Debt2     
Other liabilities210000
Other undisclosed current liabilities     (7)
Total current liabilities:272417101213
Noncurrent Liabilities
Long-term debt and lease obligation134117103   
Long-term debt, excluding current maturities126117103   
Operating lease, liability8
Liabilities, other than long-term debt231112
Other liabilities231112
Total noncurrent liabilities:136121103112
Total liabilities:163145120101314
Stockholders' equity
Stockholders' equity attributable to parent(1)9066132116147
Common stock000000
Additional paid in capital447433278255178158
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)(0)
Accumulated deficit(448)(343)(212)(122)(62)(10)
Total stockholders' equity:(1)9066132116147
TOTAL LIABILITIES AND EQUITY:162235186142129161

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues553411256
Revenue, net1   
Cost of revenue
(Cost of Goods and Services Sold)
(2)(1)(0)   
Gross profit:523311256
Operating expenses(144)(148)(88)(62)(59)(37)
Other undisclosed operating income  0   
Operating income (loss):(92)(115)(88)(61)(57)19
Nonoperating expense
(Investment Income, Nonoperating)
     (1)
Interest and debt expense(15)(19)(5)   
Other undisclosed income from continuing operations before equity method investments, income taxes231100
Income (loss) from continuing operations before income taxes:(105)(131)(91)(60)(57)18
Income tax expense (benefit)  205(7)
Net income (loss) attributable to parent:(105)(131)(89)(60)(52)10
Preferred stock dividends and other adjustments     (0)
Other undisclosed net loss available to common stockholders, basic     (1)
Net income (loss) available to common stockholders, basic:(105)(131)(89)(60)(52)9
Dilutive securities, effect on basic earnings per share     0
Net income (loss) available to common stockholders, diluted:(105)(131)(89)(60)(52)9

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(105)(131)(89)(60)(52)10
Comprehensive income (loss):(105)(131)(89)(60)(52)10
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)0(0)0(0)
Comprehensive income (loss), net of tax, attributable to parent:(105)(131)(89)(60)(52)10

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: